Robert Balk to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Robert Balk has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.129
-
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon. 2004 Apr; 50(4):168-213.
Score: 0.053
-
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995 Mar 22-29; 273(12):934-41.
Score: 0.028
-
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993 Oct 15; 119(8):771-8.
Score: 0.026
-
Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med. 1991 Aug; 19(8):1060-6.
Score: 0.022